Glaukos Technologies Featured in Numerous Presentations at the 2020 American Society of Cataract and Refractive Surgery Virtual Annual Meeting

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its technologies will be featured in various “on demand” presentations at the American Society of Cataract and Refractive Surgery (ASCRS) Virtual Annual Meeting, which will be held online on May 16-17, 2020.

KEY GLAUCOMA PRESENTATIONS:

• Brandon J. Baartman, MD
  Ocular Surface Disease Improvement in Eyes Implanted with Trabecular Meshwork Bypass Stents (iStent or iStent inject)

• John P. Berdahl, MD
  Trabecular Micro-Bypass Stent Implantation with Cataract Extraction in Open-Angle Glaucoma: Seven-Year Results

• Beau J. Billings
  Early Results of Second-Generation Trabecular Micro-Bypass Stents (iStent inject) with Cataract Surgery in a Real-World Setting

• Beau J. Billings
  Outcomes of iStent Implantation with Femtosecond Laser-Assisted Cataract Surgery versus Manual Cataract Surgery

• Tanner J. Ferguson, MD
  Second-Generation Trabecular Micro-Bypass Stent Implantation with Cataract Surgery: Early Clinical Experience

• Tanner J. Ferguson, MD
  Trabecular Micro-Bypass Stent Implantation with Cataract Extraction in Pseudoexfoliative Glaucoma: Six-Year Results

• Mark J. Gallardo, MD
  Second-Generation Trabecular Micro-Bypass Stents (iStent inject) with Cataract Surgery in Open-Angle Glaucoma: Single-Surgeon Outcomes

• Richard A. Lehrer, MD, ABO
  Long-Term Outcomes of Trabecular Bypass Stenting with Cataract Surgery Including VF, OCT and Disease Progression: Real-World Case Series

• Eva I. Liang, MD
  Early U.S. Experience with the Second-Generation Trabecular Micro-Bypass Stents in Combination with Cataract Surgery

• Richard L. Lindstrom, MD
  Sustained Five-Year Safety and IOP Outcomes in Open-Angle Glaucoma Subjects Treated with Trabecular Micro-Bypass Stents (iStent inject)

• David K. Manning, MD
  Two-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent inject) Combined with Cataract Surgery

• Ali Salimi, MSc
  Second-Generation Trabecular Micro-Bypass Stents (iStent inject) with Cataract Surgery in Normal Tension Glaucoma: One-Year Outcomes

• Thomas W. Samuelson, MD
  Long-Term Safety and Patient Reported Outcomes on Second-Generation Trabecular Micro-Bypass Stent System

• Steven R. Sarkisian Jr., MD
  Real-World U.S. Experience with Second-Generation Trabecular Micro-Bypass Stents (iStent inject) Implanted in Conjunction with Cataract Surgery

• Keith Walter, MD, ABO